[go: up one dir, main page]

NO20073294L - G protein-coupled receptor - Google Patents

G protein-coupled receptor

Info

Publication number
NO20073294L
NO20073294L NO20073294A NO20073294A NO20073294L NO 20073294 L NO20073294 L NO 20073294L NO 20073294 A NO20073294 A NO 20073294A NO 20073294 A NO20073294 A NO 20073294A NO 20073294 L NO20073294 L NO 20073294L
Authority
NO
Norway
Prior art keywords
gpr39
protein
relates
compounds
coupled receptor
Prior art date
Application number
NO20073294A
Other languages
Norwegian (no)
Inventor
Diederik Willem Elisa Moechars
Benoit Christian Jean- Moreaux
Theophiel Louis Henri Peeters
Inge Irma Therese Depoortere
Bernard Coulie
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20073294L publication Critical patent/NO20073294L/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse vedrører den funksjonelle karakterisering av den G-protein-koblede reseptor GPR39, og forbindelser som modifiserer eller regulerer GPR39-proteinaktivitet. Spesielt vedrører foreliggende oppfinnelse fremgangsmåter for å teste med hensyn til agonister eller antagonister av GPR39 for å identifisere forbindelser som har evnen til å modulere mage/tarm-kinetikken og/eller kolesterolmetabolismen, og terapeutiske anvendelser av disse forbindelser. Oppfinnelsen vedrører også transgene dyr som bærer mutasjoner i GPR39-genet.The present invention relates to the functional characterization of the G-protein-coupled receptor GPR39, and to compounds that modify or regulate GPR39 protein activity. In particular, the present invention relates to methods for testing for agonists or antagonists of GPR39 to identify compounds having the ability to modulate gastrointestinal kinetics and / or cholesterol metabolism, and therapeutic uses of these compounds. The invention also relates to transgenic animals carrying mutations in the GPR39 gene.

NO20073294A 2004-12-01 2007-06-28 G protein-coupled receptor NO20073294L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04106220 2004-12-01
PCT/EP2005/056350 WO2006058889A1 (en) 2004-12-01 2005-11-30 G protein coupled receptor

Publications (1)

Publication Number Publication Date
NO20073294L true NO20073294L (en) 2007-08-29

Family

ID=34929976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073294A NO20073294L (en) 2004-12-01 2007-06-28 G protein-coupled receptor

Country Status (10)

Country Link
EP (1) EP1820026A1 (en)
JP (1) JP2008521419A (en)
KR (1) KR20070086003A (en)
CN (1) CN101107529A (en)
AU (1) AU2005311321A1 (en)
CA (1) CA2587534A1 (en)
NO (1) NO20073294L (en)
RU (1) RU2007124609A (en)
WO (1) WO2006058889A1 (en)
ZA (1) ZA200704526B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4928260B2 (en) * 2004-04-23 2012-05-09 武田薬品工業株式会社 New screening method
WO2007141322A1 (en) * 2006-06-08 2007-12-13 Janssen Pharmaceutica N.V. G protein coupled receptor 39 (gpr39)
CN111443209B (en) * 2020-03-26 2022-12-20 中国中医科学院医学实验中心 Method for screening non-agonist PPAR gamma ligand

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001081634A2 (en) * 2000-04-26 2001-11-01 Millennium Pharmaceuticals, Inc. Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
WO2002086460A1 (en) * 2001-04-20 2002-10-31 Consensus Pharmaceuticals, Inc. Methods for identifying ligands of g-protein-coupled receptors
US20030232769A1 (en) * 2002-06-17 2003-12-18 Isis Pharmaceuticals Inc. Antisense modulation of G protein-coupled receptor 39 expression
EP1581648A2 (en) * 2002-09-09 2005-10-05 Nura, Inc. G protein coupled receptors and uses thereof
US20040071708A1 (en) * 2002-09-26 2004-04-15 Immusol, Inc. GPR 39 modulators that control cancerous cell growth
WO2004039837A2 (en) * 2002-10-31 2004-05-13 Janssen Pharmaceutica N.V. Crh responsive genes in cns
US20080038247A1 (en) * 2003-05-05 2008-02-14 Bayer Healthcare Ag Diagnostics and Therapeutics for Diseases Associated With G-Protein-Coupled Receptor Gpr39 (Gpr39)

Also Published As

Publication number Publication date
WO2006058889A1 (en) 2006-06-08
CN101107529A (en) 2008-01-16
RU2007124609A (en) 2009-01-10
JP2008521419A (en) 2008-06-26
EP1820026A1 (en) 2007-08-22
CA2587534A1 (en) 2006-06-08
ZA200704526B (en) 2008-11-26
AU2005311321A1 (en) 2006-06-08
KR20070086003A (en) 2007-08-27

Similar Documents

Publication Publication Date Title
Mompeón et al. Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1–7 production
Weyermann et al. A practical note on the use of cytotoxicity assays
EA201100062A1 (en) CONNECTIONS AND METHODS OF MODELING RECEPTORS ASSOCIATED WITH PROTEIN G
NO20083011L (en) Modulators of muscarinic receptors
MA31760B1 (en) Compositions and methods for the use of antibodies against sclerostin
ATE516300T1 (en) NEUROMEDIN-U RECEPTOR AGONISTS AND THEIR USE
EA201100133A1 (en) ANTAGONISTS OF PROSTAGLANDIN RECEPTORS D
EA200901646A1 (en) RECEPTOR THYROZINKINASE INHIBITORS AND THEIR APPLICATION
TW200607814A (en) Cell surface receptor isoforms and methods of identifying and using the same
MX2009004141A (en) Compositions and methods for modulating c-kit and pdgfr receptors.
NO20070521L (en) Methods Related to a Single Nucleotide Polymorphism of the G-Protein Coupled Receptor, GPR40
EP2318088A4 (en) ENSEMBLES AND PORTABLE SYSTEMS FOR PROVIDING FUNCTIONAL OR THERAPEUTIC NEUROSTIMULATION AND ASSOCIATED METHODS
MY159815A (en) Notch1 receptor binding agents and methods of use thereof
EA201101009A1 (en) ANTAGONISTS C5aR
ATE469895T1 (en) CGRP RECEPTOR ANTAGONISTS
MA37761A1 (en) Proteins for binding to a double receptor antagonist antigen and their uses
WO2007106721A3 (en) Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
EA201171081A1 (en) INDOL DERIVATIVES AS AN ANTAGONISTS OF CRTH2 RECEPTOR
NO20061074L (en) Compounds and compositions as inhibitors of receptor tyrosine kinase activity
WO2009059150A3 (en) Biomarkers for fatty liver disease and methods using the same
MX2010002004A (en) 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors.
WO2007131219A3 (en) Cannabinoid receptor antagonists/inverse agonists
NO20074143L (en) Phuman T2R receptors for Acetaminophen, Ranitidine, Strychnine and Denatonium and related assays for the identification of human bitter taste modulators
WO2006096487A3 (en) Methods and compositions for modulating tweak and fn14 activity
MX2009003981A (en) Calcium receptor modulating agents.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application